Literature DB >> 26813305

Progress in the Use of Autologous Regenerative Platelet-based Therapies in Implant Dentistry.

Eduardo Anitua, María Troya, Mar Zalduendo, Ricardo Tejero, Gorka Orive1.   

Abstract

The field of medicine is rapidly moving towards the development of personalized treatments and non-invasive tools to achieve a more predictable and optimal tissue regeneration. In this sense, the goal of periodontal healing is to arrest disease progression and functionally regenerate all the tissues that comprise the periodontium. The latter implies a well-orchestrated interaction among oral cells, growth factors and extracellular matrix. Although several procedures are performed in an attempt to regenerate lost periodontal tissue, outcomes are not always predictable. Growth factors represent a class of biologically active polypeptides that have a critical role in the healing process. Their use provides a new paradigm to understand the regenerative medicine. The use of platelet- rich plasma (PRP) products as a local source and delivery system of autologous growth factors has emerged recently. Among them, PRGF stands for its remarkable stimulatory effect on oral tissue regeneration, making it a very safe and successful tool with a great value in Dentistry.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26813305     DOI: 10.2174/1389201017666160127110300

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  6 in total

1.  A novel personalized 3D injectable protein scaffold for regenerative medicine.

Authors:  Eduardo Anitua; Ander Pino; María Troya; Pedro Jaén; Gorka Orive
Journal:  J Mater Sci Mater Med       Date:  2017-12-14       Impact factor: 3.896

2.  Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-β1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A/VEGF Receptor-1-Mediated Signaling .

Authors:  Flaminia Chellini; Alessia Tani; Larissa Vallone; Daniele Nosi; Paola Pavan; Franco Bambi; Sandra Zecchi Orlandini; Chiara Sassoli
Journal:  Cells       Date:  2018-09-19       Impact factor: 6.600

3.  Hypoxia Preconditioned Serum (HPS) Promotes Osteoblast Proliferation, Migration and Matrix Deposition.

Authors:  Jun Jiang; Lynn Röper; Sarah Alageel; Ulf Dornseifer; Arndt F Schilling; Ektoras Hadjipanayi; Hans-Günther Machens; Philipp Moog
Journal:  Biomedicines       Date:  2022-07-07

4.  Autologous Platelet Rich Plasma (PRGF) Preserves Genomic Stability of Gingival Fibroblasts and Alveolar Osteoblasts after Long-Term Cell Culture.

Authors:  Eduardo Anitua; María de la Fuente; María Troya; Mar Zalduendo; Mohammad Hamdan Alkhraisat
Journal:  Dent J (Basel)       Date:  2022-09-14

5.  Plasma rich in growth factors (PRGF) and leukocyte-platelet rich fibrin (L-PRF): comparative release of growth factors and biological effect on osteoblasts.

Authors:  Laura Baca-Gonzalez; Rebeca Serrano Zamora; Lisa Rancan; Francisco González Fernández-Tresguerres; Isabel Fernández-Tresguerres; Rosa M López-Pintor; Juan López-Quiles; Isabel Leco; Jesús Torres
Journal:  Int J Implant Dent       Date:  2022-10-03

6.  Dual-Function Semaphorin 4D Released by Platelets: Suppression of Osteoblastogenesis and Promotion of Osteoclastogenesis.

Authors:  Satoru Shindo; Irma Josefina Savitri; Takenobu Ishii; Atsushi Ikeda; Roodelyne Pierrelus; Alireza Heidari; Keisuke Okubo; Shin Nakamura; Umadevi Kandalam; Mohamad Rawas-Qalaji; Elizabeth Leon; Maria Rita Pastore; Patrick Hardigan; Toshihisa Kawai
Journal:  Int J Mol Sci       Date:  2022-03-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.